From January 1, 2024 to March 31, 2024, the company has repurchased 62,607 shares, representing 2.15% for $0.1 million. With this, the company has completed the repurchase of 315,462 shares, representing 10.37% for $0.57 million under the buyback announced on January 31, 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.88 USD | -0.53% | +6.58% | +31.75% |
Apr. 23 | Silo Pharma, Inc. Announces Positive Results for Intranasal PTSD Treatment | CI |
Apr. 10 | Silo Pharma Says It Exercised Option to License Alzheimer's Therapeutic From Columbia University | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+31.75% | 5.37M | |
-3.45% | 87.17B | |
+1.97% | 40.1B | |
-17.16% | 31.38B | |
+57.98% | 25.12B | |
-15.92% | 15.59B | |
-8.82% | 12B | |
-41.58% | 11.8B | |
-16.11% | 11.8B | |
+6.89% | 8.81B |
- Stock Market
- Equities
- SILO Stock
- News Silo Pharma, Inc.
- Tranche Update on Silo Pharma, Inc.'s Equity Buyback Plan announced on January 31, 2023.